Recruiting Mantle Cell Lymphoma Studies in Chicago
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma
The goal of this study is to compare how well sonrotoclax plus zanubrutinib works versus zanubrutinib plus placebo in treating adults with relapsed/refractory (R/R) mantle cell lymphoma (MCL). This st...
Avo In R/R And Previously Untreated MCL
This research study is evaluating the combination of three drugs - acalabrutinib, venetoclax, and obinutuzumab - as a possible treatment for relapsed or refractory and untreated mantle cell lymphoma (...
About Mantle Cell Lymphoma Clinical Trials in Chicago
Mantle cell lymphoma (MCL) is a rare, aggressive type of non-Hodgkin lymphoma that develops from B-cells in the mantle zone of lymph nodes. It accounts for about 5-7% of all NHL cases. Treatment includes combination chemotherapy, targeted therapy, and stem cell transplant.
There are currently 2 mantle cell lymphoma clinical trials recruiting participants in Chicago, ILLINOIS. These studies are seeking a combined 353 participants. Research is being sponsored by BeiGene, Austin I Kim. Clinical trial participation is free and participants receive study-related medical care at no cost.
Mantle Cell Lymphoma Clinical Trials in Chicago — FAQ
Are there mantle cell lymphoma clinical trials in Chicago?
Yes, there are 2 mantle cell lymphoma clinical trials currently recruiting in Chicago, ILLINOIS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chicago?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.
Are clinical trials in Chicago free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.
What mantle cell lymphoma treatments are being tested?
The 2 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for mantle cell lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov